# Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

> **NCT00525590** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 69 (actual)

## Conditions studied

- Metastatic Brain Cancer

## Interventions

- **DRUG:** GLIADEL

## Key facts

- **NCT ID:** NCT00525590
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-12
- **Primary completion:** 2010-12-01
- **Final completion:** 2010-12-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525590, "Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00525590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*